Bioserve Biotechnologies India Pvt. Ltd.
Mandar Kulkarni - Chief Technology Officer
My journey in healthcare, starting with a PhD in molecular cell biology focusing on cancer, led to a career shift during my postdoctoral fellowship at Yale. I became the first employee of a molecular diagnostics startup, transitioning from molecular carcinogenesis to clinical microbiology. Over three years, I developed clinical assays for antibiotic resistance and managed a genomics division. These experiences prepared me for Cancer Genetics Inc.'s goals in India, focusing on next-generation sequencing (NGS) for personalized cancer diagnostics. NGS technology enhanced our ability to analyze genetic aberrations comprehensively, solidifying our role in personalized cancer care.